更少辐射,相同质量:约1毫希沃特对比增强多排CT对胸部淋巴结的显示研究
这项单机构回顾性匹配病例对照研究比较了约1 mSv的低剂量对比增强胸部CT与标准剂量对比增强胸部CT对胸部淋巴结的显示能力。结果显示两组在IASLC各区域可测量淋巴结显示率无显著差异,低剂量组有效剂量为1.0 ± 0.3 mSv,标准剂量组为3.4 ± 1.5 mSv。
要点
- 低剂量对比增强胸部CT(约1 mSv)与标准剂量CT对胸部淋巴结的显示率无显著差异。
- 低剂量组有效剂量1.0 ± 0.3 mSv,标准剂量组3.4 ± 1.5 mSv。
- 一名观察者在低剂量组显示更多周围区淋巴结,其余区域无显著差异。
核心结论
- 约1 mSv的低剂量对比增强胸部CT与标准剂量对比增强胸部CT对胸部淋巴结的显示能力相当。
研究设计与样本
- 伦理委员会批准的单机构回顾性(20个月)匹配病例对照研究,62例低剂量对比增强胸部CT病例与124例标准剂量对比增强胸部CT对照,采用64排多排CT自动曝光控制调节并迭代图像重建。
诊断标准与关键数值
- 可测量淋巴结显示以是/否判定,在六个IASLC区域(上纵隔、主肺动脉窗、隆突下、下纵隔、肺门、周围区)进行比较;淋巴结大小截断值为1 cm;低剂量组管电压100 KVp、CT剂量指数1.66 ± 0.51 mGy,标准剂量组管电压120 KVp、CT剂量指数5.36 ± 2.24 mGy。
局限性
- 原文为单机构回顾性研究。
- 淋巴结大小(截断值1 cm)为潜在的事后混杂因素。
- 一名观察者在低剂量组显示更多周围区淋巴结,其余区域无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Mediastinal, hilar, and peripheral pulmonary lymphadenopathy is a hallmark sign of different benign and malignant diseases of the chest. Contrast-enhanced (CE) chest CT is a test frequently applied to examine thoracic lymph node zones. We attempted to find out whether mediastinal, hilar, and peripheral lymph nodes delineate equally in CE chest CT with reduced dose (CE-LDCT, about 1 mSv) when compared with accepted standard CE chest CT (CE-SDCT).
MATERIALS AND METHODS: In this ethics committee-approved, mono-institutional, retrospective (20 months) matched case-control study, two independent, blinded observers compared measurable lymph node delineation (yes-no) in six different International Association for the Study of Lung Cancer (IASLC) zones (upper mediastinal, aortopulmonary, subcarinal, lower mediastinal, hilar, peripheral) between 62 CE-LDCT cases and 124 CE-SDCT controls (respective tube charge, 100, 120 KVp, computed tomography dose index, 1.66 ± 0.51, 5.36 ± 2.24 mGy, automatic exposure control-modulated 64-row multi-detector chest CT with iterative image reconstruction). Individual matching for gender (53% female), age (53 ± 19 years), body height, weight, anterior-posterior and transverse diameters of chest and lung ruled out pre-test confounders. Lymph node size (cut-off value, 1 cm) was a potential post-test confounder. Two-tailed T test and Chi-square test were significant for p < 0.05.
RESULTS: Measurable lymph nodes delineated equally in cases (261/372 IASLC zones, 70%; 280/372, 75%) and controls (528/744, 71%; 519/744, 70%; no significant differences, power 90%). One observer delineated significantly more peripheral zone lymph nodes in cases (35/62) than in controls (43/124); there were no significant differences otherwise. Lymph node size did not differ significantly; effective dose was 1.0 ± 0.3 mSv in cases and 3.4 ± 1.5 mSv in controls.
CONCLUSION: CE-LDCT with about 1 mSv demonstrated equal delineation of thoracic lymph nodes when compared with accepted standard CE-SDCT.
引用
- Mueller-Lisse UG, Marwitz L, Tufman A, et al. Less radiation, same quality: contrast-enhanced multi-detector computed tomography investigation of thoracic lymph nodes with one milli-sievert. Radiol Med. 2018. PMID: 29961228. doi:10.1007/s11547-018-0915-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。